N,N-Dimethyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzenesulfonamide, 97%, 1g

3-Bromo-2-methylpyridine>98.0%(GC)1g

GC-Kapillarsäule ROTI®Cap-1 MS, 50 m, 0.20 mm, 0.20 µm, unpolar, 1 Stück

Methyl 3-methyl-2-(3-methylisoxazol-5-yl)butanoate, 98%, 100mg

methyl 4-bromo-5-methyl-1H-pyrrole-2-carboxylate, 95.0%, 100mg

tert-butyl 2,2-dimethyl-4-oxo-1-piperidinecarboxylate, 95.0%, 100g

2-METHYL-5-[4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL]-1,3,4-OXADIAZOLE, 95.0%, 1g

3-Iodo-2-methoxybenzoic acid, 97%, 100mg

2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(ethyl)amino)-2-methylpropanoic acid, 97%, 1g

Objektträger 76 x 26 mm, Weißglas, Kanten geschliffen. Verpackt zu 50 Stück

Sodium 2-Amino-4-chloro-5-methylbenzenesulfonate>98.0%(HPLC)(N)25g

2-Bromo-9-phenylcarbazole>98.0%(GC)(N)5g

3-HYDROXYPYRROLIDINE-2-CARBOXYLIC ACID, 95%, 250mg